SBIR/STTR Research Award

Development of Biological Obscurants

Award identifier 013a5b018a63ea7f42cd46f2a712f7742376919b52e7219258978410e5ad8b55Awarding agency Department of Defense · Army

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

1998

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
Systems & Processes Engineering Corporation
Proposal award date
Not reported
Contract end date
Not reported
UEI
M5JVFYWW75P1
Solicitation number
Not reported
Topic code
Not reported

Research abstract

SPEC and Dr. James P. Chambers of the University of Texas at San Antonio propose to develop biological obscurants for battlefield applications based on the use of bacteriochlorophylls. In this Phase I program, SPEC and Dr. Chambers will conduct spectroscopic investigations of bacteria containing bacteriochlorophyll b with tetrapyrrole pigments to demonstrate the feasibility of using chlorophyll compounds as obscurants. Also in the Phase I, we will investigate the use of combinatorial techniques to alter the protein microenvironment near the tetrapyrrole ring and thus tune the absorption spectra to provide multi-spectral capabilities. The rational for use of chlorophyll compounds as an obscurant is based on the broad range of spectral absorption possible using chlorophyll derivatives. Observed absorption peaks coincide well with specific areas of military interest including: (1) the visible range; (2) night vision ranges including 700 to 800 for older systems and 900 for 3rd generation image tube technology; and (3) the 1064 nm range for most smart bomb and missile laser guidance systems. Based on these absorption spectra, bacteriochlorophyll compounds are excellent candidate compounds to investigate as replacements for obscurants currently in use which have a number of shortcomings including: limited spectral ranges, cleanup requirements, and toxic effects. BENEFITS: Biological obscurants could provide multi-spectral capabilities, environmental-friendly biodegradation, and non-pathogenic constituents and by-products. Other advantages could come in the manufacturing process by providing low-cost, rapid production and simplified storage and transport. It is conceivable that production of large quantities of obscurant could take place in forward locations from only small quantities biologically active cells.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

206 SBIR/STTR records share this UEI (1987–2025). Reported award amounts total $59,199,771. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Homeland Security, Department of Energy, Environmental Protection Agency, National Science Foundation

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.